Stock Track | Septerna (SEPN) Soars 5.55% as HC Wainwright Maintains Buy Rating and Raises Price Target

Stock Track11-11

Shares of Septerna, Inc. (SEPN) are soaring 5.55% in Tuesday's intraday trading session, following positive analyst actions from HC Wainwright & Co. The biotechnology company's stock is gaining momentum as investors react to the latest bullish outlook from Wall Street.

HC Wainwright & Co. has reaffirmed its Buy rating on Septerna, demonstrating continued confidence in the company's prospects. In addition to maintaining the positive rating, the firm has significantly raised its price target for Septerna from $26 to $30, suggesting substantial upside potential from current levels.

The upgraded price target and maintained Buy rating indicate that analysts at HC Wainwright see strong growth opportunities for Septerna in the near future. This positive sentiment is likely driving the notable surge in the company's stock price as investors align their positions with the bullish analyst view. As the trading session progresses, market participants will be watching closely to see if Septerna can maintain its upward momentum in response to this encouraging analyst update.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1104435434?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-11-11 23:06","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1104435434","market":"nz","top_or_hot":-1,"title":"Stock Track | Septerna (SEPN) Soars 5.55% as HC Wainwright Maintains Buy Rating and Raises Price Target","media":"Stock Track","content":"<p>Shares of Septerna, Inc. (SEPN) are soaring 5.55% in Tuesday's intraday trading session, following positive analyst actions from HC Wainwright & Co. The biotechnology company's stock is gaining momentum as investors react to the latest bullish outlook from Wall Street.</p>\n\n<p>HC Wainwright & Co. has reaffirmed its Buy rating on Septerna, demonstrating continued confidence in the company's prospects. In addition to maintaining the positive rating, the firm has significantly raised its price target for Septerna from $26 to $30, suggesting substantial upside potential from current levels.</p>\n\n<p>The upgraded price target and maintained Buy rating indicate that analysts at HC Wainwright see strong growth opportunities for Septerna in the near future. This positive sentiment is likely driving the notable surge in the company's stock price as investors align their positions with the bullish analyst view. As the trading session progresses, market participants will be watching closely to see if Septerna can maintain its upward momentum in response to this encouraging analyst update.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Septerna (SEPN) Soars 5.55% as HC Wainwright Maintains Buy Rating and Raises Price Target</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Septerna (SEPN) Soars 5.55% as HC Wainwright Maintains Buy Rating and Raises Price Target\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2025-11-11 23:06</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Shares of Septerna, Inc. (SEPN) are soaring 5.55% in Tuesday's intraday trading session, following positive analyst actions from HC Wainwright & Co. The biotechnology company's stock is gaining momentum as investors react to the latest bullish outlook from Wall Street.</p>\n\n<p>HC Wainwright & Co. has reaffirmed its Buy rating on Septerna, demonstrating continued confidence in the company's prospects. In addition to maintaining the positive rating, the firm has significantly raised its price target for Septerna from $26 to $30, suggesting substantial upside potential from current levels.</p>\n\n<p>The upgraded price target and maintained Buy rating indicate that analysts at HC Wainwright see strong growth opportunities for Septerna in the near future. This positive sentiment is likely driving the notable surge in the company's stock price as investors align their positions with the bullish analyst view. As the trading session progresses, market participants will be watching closely to see if Septerna can maintain its upward momentum in response to this encouraging analyst update.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"SEPN","symbol_name":"Septerna, Inc.","start_time":0,"source_url":"","article_id":"1104435434","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1104435434","pubTimestamp":1762873579,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Shares of Septerna, Inc. (SEPN) are soaring 5.55% in Tuesday's intraday trading session, following positive analyst actions from HC Wainwright & Co. The biotechnology company's stock is gaining...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"SEPN":"Septerna, Inc."},"translate_title":"股票追踪|Septerna(SEPN)飙升5.55%，HC Wainwright维持买入评级并上调目标价","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"SEPN":1},"content_text":"Shares of Septerna, Inc. (SEPN) are soaring 5.55% in Tuesday's intraday trading session, following positive analyst actions from HC Wainwright & Co. The biotechnology company's stock is gaining momentum as investors react to the latest bullish outlook from Wall Street.\nHC Wainwright & Co. has reaffirmed its Buy rating on Septerna, demonstrating continued confidence in the company's prospects. In addition to maintaining the positive rating, the firm has significantly raised its price target for Septerna from $26 to $30, suggesting substantial upside potential from current levels.\nThe upgraded price target and maintained Buy rating indicate that analysts at HC Wainwright see strong growth opportunities for Septerna in the near future. This positive sentiment is likely driving the notable surge in the company's stock price as investors align their positions with the bullish analyst view. As the trading session progresses, market participants will be watching closely to see if Septerna can maintain its upward momentum in response to this encouraging analyst update.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1104435434","isCrawlerRequest":true}